36 results
DEF 14C
BGLC
BioNexus Gene Lab Corp
29 Feb 24
Information statement
5:16pm
–
a commitment to long-term value creation for our stockholders;
an appreciation for stockholder feedback;
high personal and professional ethics;
a proven … , to improve long-term organizational performance and enhance stockholder value. A fundamental part of risk oversight is not only understanding
PRE 14C
BGLC
BioNexus Gene Lab Corp
26 Jan 24
Preliminary information
4:05pm
. Subsequently the candidates will be evaluated to ensure they possess these key characteristics –
a commitment to long-term value creation for our … oversight, designed to support the achievement of organizational objectives, including strategic objectives, to improve long-term organizational performance
8-K
EX-1.1
2dvbo18p8mvt 1i
24 Jul 23
BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:28pm
424B4
esqp7
21 Jul 23
Prospectus supplement with pricing info
3:37pm
DEF 14C
7kq65
17 May 23
Information statement
9:07am